Overview
Israel digital forensics firm's Q1 revenue grew 19%, beating analyst expectations
Adjusted EBITDA for Q1 beat analyst estimates; net income missed expectations
Company closed SCG Canada acquisition, expanding drone forensics capabilities
Outlook
Cellebrite expects Q2 revenue of $130 mln to $133 mln
Company sees full-year 2026 revenue of $565 mln to $571 mln
Cellebrite projects Q2 ARR of $510 mln to $513 mln
Result Drivers
SUBSCRIPTION GROWTH - Q1 subscription revenue rose 23% year-over-year, supporting overall revenue growth
NEW PRODUCT OFFERINGS - Co cited strong customer response to new AI-powered solutions, including Guardian Investigate and Genesis, as contributing to results
DRONE FORENSICS EXPANSION - Acquisition of SCG Canada broadened digital forensics capabilities to include drones, an emerging device category
Company press release: ID:nPn18HqBDa
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$128.3 mln
$126.85 mln (7 Analysts)
Q1 Net Income
Miss
$10.94 mln
$23.91 mln (4 Analysts)
Q1 Adjusted EBITDA
Beat
$30.62 mln
$27.16 mln (6 Analysts)
Q1 Gross Margin
82.50%
Q1 Cash Flow from Operating Activities
$19.89 mln
Q1 Operating Income
$9.12 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the software peer group is "buy"
Wall Street's median 12-month price target for Cellebrite DI Ltd is $21.00, about 73.6% above its May 13 closing price of $12.10
The stock recently traded at 21 times the next 12-month earnings vs. a P/E of 27 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)